We are live on ! Find out more
VWM

Vigilare Wealth Management Portfolio holdings

AUM $326M
1-Year Est. Return 21.58%
This Fund
S&P 500
This Quarter Est. Return
+11.32%
1 Year Est. Return
+21.58%
3 Year Est. Return
+56.88%
5 Year Est. Return
+49.16%
10 Year Est. Return
AUM
$106M
AUM Growth
+$9.56M
Cap. Flow
+$1.25M
Cap. Flow %
1.18%
Top 10 Hldgs %
33.31%
Holding
172
New
34
Increased
39
Reduced
65
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 17.99%
2 Healthcare 11.9%
3 Communication Services 9.38%
4 Consumer Discretionary 9.33%
5 Consumer Staples 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWPH
126
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$214K 0.2%
+1,850
New +$207K
KMB icon
127
Kimberly-Clark
KMB
$36.5B
$213K 0.2%
1,580
-1,900
-55% -$266K
RPG icon
128
Invesco S&P 500 Pure Growth ETF
RPG
$2.09B
$213K 0.2%
+6,540
New +$199K
SRPT icon
129
Sarepta Therapeutics
SRPT
$1.77B
$211K 0.2%
+1,240
New +$184K
FOLD
130
DELISTED
Amicus Therapeutics
FOLD
$210K 0.2%
9,100
-4,700
-34% -$96.1K
BLK icon
131
Blackrock
BLK
$176B
$208K 0.2%
+288
New +$191K
NBIX icon
132
Neurocrine Biosciences
NBIX
$16.6B
$208K 0.2%
+2,170
New +$210K
BX icon
133
Blackstone
BX
$110B
$207K 0.2%
3,200
-1,000
-24% -$58.2K
UPS icon
134
United Parcel Service
UPS
$88.9B
$207K 0.2%
1,230
+20
+2% +$3.38K
MRKR icon
135
Marker Therapeutics
MRKR
$18.7M
$206K 0.2%
14,175
+1,330
+10% +$20.6K
PFF icon
136
iShares Preferred and Income Securities ETF
PFF
$13.3B
$206K 0.2%
+5,354
New +$200K
TGTX icon
137
TG Therapeutics
TGTX
$7.62B
$205K 0.19%
+3,950
New +$133K
ROBO icon
138
ROBO Global Robotics & Automation Index ETF
ROBO
$2.1B
$203K 0.19%
+3,327
New +$180K
VCIT icon
139
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$200K 0.19%
+2,059
New +$198K
VWO icon
140
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$200K 0.19%
+4,000
New +$188K
TCON
141
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$164K 0.16%
700
-150
-18% -$20.9K
SGMO
142
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$161K 0.15%
10,300
-11,340
-52% -$133K
CLVS
143
DELISTED
Clovis Oncology, Inc.
CLVS
$155K 0.15%
32,200
-3,850
-11% -$19.5K
EQ icon
144
Equillium
EQ
$133M
$142K 0.13%
+26,600
New +$139K
GE icon
145
GE Aerospace
GE
$384B
$137K 0.13%
+2,550
New +$114K
ONCT
146
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$110K 0.1%
+1,125
New +$71.2K
ADAP
147
DELISTED
Adaptimmune Therapeutics
ADAP
$94K 0.09%
+17,500
New +$95.1K
AMRN
148
Amarin Corp
AMRN
$303M
$92K 0.09%
939
-200
-18% -$19.3K
NOK icon
149
Nokia
NOK
$52.3B
$47K 0.04%
12,000
BCRX icon
150
BioCryst Pharmaceuticals
BCRX
$2.4B
-14,500
Closed -$50K

Similar funds

Vigilare Wealth Management's Q4 2020 Portfolio in Review

As of Q4 2020, Vigilare Wealth Management held 172 positions worth $106M, up 10% from $96M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Vigilare Wealth Management's Q4 2020 filing shows 34 new, 39 increased, 65 reduced and 23 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 26,255 shares worth $1.33M. The largest sale was ProShares Short S&P500, an estimated $1.97M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.

  • Vigilare Wealth Management's largest Q4 2020 buy was Invesco Ultra Short Duration ETF: 26,255 shares worth $1.33M.
  • Vigilare Wealth Management added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q4 2020, an estimated $1.47M increase.
  • Vigilare Wealth Management's biggest Q4 2020 reduction was ProShares Short S&P500, cutting an estimated $1.97M.
  • Vigilare Wealth Management fully exited ProShares Short QQQ in Q4 2020, selling an estimated $496K.
  • Vigilare Wealth Management's ten largest holdings make up 33% of its $106M portfolio in Q4 2020.
  • Vigilare Wealth Management opened 34 new positions and closed 23 in Q4 2020.
  • Vigilare Wealth Management's portfolio value rose 10% quarter-over-quarter to $106M.

Based on Vigilare Wealth Management's 13F filing for Q4 2020, filed 14 Jan 2021.